单中心经验:静脉腔内消融术后取消常规复式超声筛查的结局
该单中心前瞻性队列研究纳入2021年9月30日至2022年3月15日连续接受大隐静脉腔内消融的76例患者共80例次手术,术后30天评估静脉血栓栓塞症状。未常规行复式超声筛查未影响临床结局,估计节省总费用14,289美元,作者认为将筛查限于有症状患者可能具有成本效益,但需进一步研究。
要点
- 静脉腔内消融术后取消常规复式超声筛查,30天内未发现静脉血栓栓塞症状或临床显著的内源性热诱导血栓形成。
- 80例次手术中24例接受术后复式超声,均未发现内源性热诱导血栓形成。
- 取消常规筛查估计节省总费用14,289美元,作者认为将筛查限于有症状患者可能具有成本效益。
核心结论
- 静脉腔内消融术后复式超声评估伴随医疗成本且产出低,因为临床显著的内源性热诱导血栓形成(3级和4级)罕见。
- 在本中心经验中,取消常规复式超声未影响临床结局,改善了血管实验室可及性,并对本机构产生积极财务影响。
- 作者认为将复式超声筛查限于出现静脉血栓栓塞症状的静脉腔内消融患者可能是一种成本效益方法,可减少不必要的影像、时间和资源,且基于本数据临床结局无潜在改变。
- 作者指出需要进一步研究,随机对照试验将是回答该问题的理想方式。
研究设计与样本
- 单中心、前瞻性队列研究,纳入2021年9月30日至2022年3月15日期间在本机构连续接受大隐静脉静脉腔内消融的患者。
- 共76例患者接受80例次下肢静脉腔内消融(71例次静脉腔内激光消融和9例次射频消融)。
- 术后30天查询电子病历以识别可能因静脉血栓栓塞症状就诊的患者。
主要发现
- 80例次手术中,24例患者接受术后复式超声,均未发现内源性热诱导血栓形成。
- 54例未接受复式超声的患者中,术后30天病历审查显示无患者因静脉血栓栓塞症状就诊。
- 估计取消常规复式超声节省总费用14,289美元,且未影响静脉腔内消融后的临床结局。
关键数值与推荐
- 当前指南推荐静脉腔内消融术后常规复式超声筛查,为2C级推荐。
- 术后30天查询电子病历以识别可能因静脉血栓栓塞症状就诊的患者。
临床怎么用
- 作者认为将复式超声筛查限于出现静脉血栓栓塞症状的静脉腔内消融患者可能是一种成本效益方法,可减少不必要的影像、时间和资源,且基于本数据临床结局无潜在改变。
- 作者指出需要进一步研究,随机对照试验将是回答该问题的理想方式。
局限性
- 作者指出需要进一步研究,随机对照试验将是回答该问题的理想方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The current guidelines recommend routine postoperative duplex ultrasound (DUS) screening after endovenous ablation (EVA). This is a grade 2C recommendation, and several contemporary reports have called for revision of this recommendation as there is insufficient evidence to support universal DUS screening after EVA. There are currently no studies that evaluate outcomes among EVA patients who did not have DUS screening. The aim of our study is to present outcomes from our single-center experience among patients who did not have DUS routinely performed after EVA. METHODS: We performed a single-center, prospective cohort study that included consecutive patients who underwent EVA of the great saphenous vein at our institution between September 30, 2021, and March 15, 2022. At 30 days after the procedure, electronic medical records were queried to identify patients who may have presented for the evaluation of venous thromboembolism (VTE) symptoms. RESULTS: Over the study period, a total of 80 lower extremity EVA procedures (71 endovenous laser ablation and 9 radiofrequency ablation) were performed among 76 patients. Postoperative DUS was performed on 24 patients, of whom none were identified as having endovenous heat-induced thrombosis. Of the 54 patients who did not have DUS, a 30-day postprocedure chart review revealed that none of these patients were seen for symptoms of VTE. We estimate total cost savings of $14,289 by eliminating routine DUS without impact to clinical outcomes after EVA. CONCLUSIONS: Postoperative DUS assessment after EVA comes with associated health care cost and has low yield given that the incidence of clinically significant endovenous heat-induced thrombosis (3 and 4) is rare. In our experience, eliminating routine DUS had no impact on clinical outcomes, improved vascular lab access, and had a positive financial impact in our organization. Limiting DUS screening to EVA patients who exhibit symptoms of VTE can be a cost-effective approach that limits unnecessary imaging, time, and resources with no potential change in clinical outcomes based on our data. Further research is required, and a randomized controlled trial would be ideal to answer this question.
引用
- Woodhouse E, DiMusto P. Outcomes of a single-center experience in eliminating routine postoperative duplex ultrasound screening after endovenous ablation. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 36935080. doi:10.1016/j.jvsv.2023.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。